{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:28:31Z","timestamp":1794464911300,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873917"],"award-info":[{"award-number":["81873917"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2023.e23455","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T23:01:16Z","timestamp":1701990076000},"page":"e23455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Transjugular intrahepatic portosystemic shunt for the treatment of hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids: A multicenter retrospective study"],"prefix":"10.1016","volume":"10","author":[{"given":"Chaoyang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongtu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanzhang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e23455_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"Vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e23455_bib2","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2352-3026(19)30201-7","article-title":"Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement","volume":"7","author":"Mahadeo","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.heliyon.2023.e23455_bib3","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1038\/s41375-021-01203-7","article-title":"Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia","volume":"35","author":"Stanulla","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.heliyon.2023.e23455_bib4","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.bbmt.2019.02.018","article-title":"Risk factors for development of and progression of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"25","author":"Corbacioglu","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.heliyon.2023.e23455_bib5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjh.15267","article-title":"Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"181","author":"Kernan","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.heliyon.2023.e23455_bib6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jgh.14612","article-title":"Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome","volume":"34","author":"Zhuge","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e23455_bib7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","article-title":"Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum","volume":"54","author":"Lin","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e23455_bib8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41401-018-0155-y","article-title":"Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors","volume":"40","author":"Zhang","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2023.e23455_bib9","first-page":"345","article-title":"Validation of the nanjing criteria for diagnosing pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome","volume":"9","author":"Zhang","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.heliyon.2023.e23455_bib10","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.3748\/wjg.v25.i28.3753","article-title":"Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes","volume":"25","author":"Yang","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e23455_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12072-021-10293-5","article-title":"Development of a Drum Tower Severity Scoring (DTSS) system for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome","volume":"16","author":"Wang","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.heliyon.2023.e23455_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24240","article-title":"Plateletcrit for predicting prognosis in patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloid","volume":"36","author":"Tu","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.heliyon.2023.e23455_bib13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/liv.15475","article-title":"Enoxaparin attenuates pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expression","volume":"43","author":"Xiang","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.heliyon.2023.e23455_bib14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s12072-020-10126-x","article-title":"Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt","volume":"15","author":"Xiao","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.heliyon.2023.e23455_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12876-018-0879-7","article-title":"Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e23455_bib16","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/liv.13684","article-title":"Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease","volume":"38","author":"Zhuge","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.heliyon.2023.e23455_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110630","article-title":"TIPS placement as the first-line therapy to prevent variceal rebleeding in patients with cirrhosis and sarcopenia","volume":"158","author":"Xiong","year":"2023","journal-title":"Eur. J. Radiol."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2023.e23455_bib18","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1016\/j.acra.2023.03.011","article-title":"The added value of sarcopenia on existing risk scores to predict mortality after TIPS placement: a multicenter study","volume":"30","author":"Xiong","year":"2023","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.heliyon.2023.e23455_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S2468-1253(19)30090-1","article-title":"Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial","volume":"4","author":"Lv","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.heliyon.2023.e23455_bib20","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garcia-Pagan","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e23455_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","article-title":"Role of liver sinusoidal endothelial cells in liver diseases","volume":"18","author":"Gracia-Sancho","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e23455_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2023.e23455_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2023.e23455_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1148\/radiol.211172","article-title":"Sarcopenia in patients with cirrhosis after transjugular intrahepatic portosystemic shunt placement","volume":"303","author":"Liu","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.heliyon.2023.e23455_bib25","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jvir.2010.06.009","article-title":"Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft\/bare stent combination","volume":"21","author":"Saad","year":"2010","journal-title":"J. Vasc. Intervent. Radiol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023106633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023106633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:21:47Z","timestamp":1790655707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023106633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844023106633"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23455","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transjugular intrahepatic portosystemic shunt for the treatment of hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids: A multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e23455"}}